AbCellera Biologics
(NASDAQ:ABCL)
$4.0599
0.2099[5.45%]
At close: May 3
$4.0599
0[0.00%]
After Hours: 7:57PM EDT
Q1 2024 Earnings in 3 days from now on Tue May 7th, after the market close
Conference call scheduled in 3 days at 17:00 PM Click to view the webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

AbCellera Biologics Stock (NASDAQ:ABCL), Quotes and News Summary

AbCellera Biologics Stock (NASDAQ: ABCL) stock price, news, charts, stock research, profile.

Open$3.920
Close$4.030
Volume / Avg.2.203M / 1.385M
Day Range3.920 - 4.200
52 Wk Range3.620 - 8.050
Market Cap$1.193B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
48
Short Interest
10.44%
Days to Cover25.18

Recent News

Why AbCellera Biologics Is Still A Buy Despite Dropping Royalties: Analyst On Long-Term Prospects
Benchmark analyst Robert Wasserman reiterated a Buy rating on AbCellera Biologics Inc. (NASDAQ: ABCL), 
Nabaparna Bhattacharya
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.
Lisa Levin
Apple, Fortinet, Microchip Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
2
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ABCL
MEDP

FAQ

Q

How do I buy AbCellera Biologics (ABCL) stock?

A

You can purchase shares of AbCellera Biologics (NASDAQ: ABCL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are AbCellera Biologics's (ABCL) competitors?

A

Other companies in AbCellera Biologics’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).

Q

What is the target price for AbCellera Biologics (ABCL) stock?

A

The latest price target for AbCellera Biologics (NASDAQ: ABCL) was reported by Benchmark on Thursday, February 22, 2024. The analyst firm set a price target for 0.00 expecting ABCL to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for AbCellera Biologics (ABCL)?

A

The stock price for AbCellera Biologics (NASDAQ: ABCL) is $4.0599 last updated May 3, 2024 at 7:57 PM EDT.

Q

Does AbCellera Biologics (ABCL) pay a dividend?

A

There are no upcoming dividends for AbCellera Biologics.

Q

When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?

A

AbCellera Biologics’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Q

Is AbCellera Biologics (ABCL) going to split?

A

There is no upcoming split for AbCellera Biologics.

Q

What sector and industry does AbCellera Biologics (ABCL) operate in?

A

AbCellera Biologics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch